Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.
de Wit D, Schneider TC, Moes DJ, Roozen CF, den Hartigh J, Gelderblom H, Guchelaar HJ, van der Hoeven JJ, Links TP, Kapiteijn E, van Erp NP.
de Wit D, et al. Among authors: van erp np, van der hoeven jj.
Cancer Chemother Pharmacol. 2016 Jul;78(1):63-71. doi: 10.1007/s00280-016-3050-6. Epub 2016 May 11.
Cancer Chemother Pharmacol. 2016.
PMID: 27169792
Free PMC article.
Clinical Trial.